Study Data Technical Conformance Guide - Technical Specifications Document
The FDA issued an updated Study Data Technical Conformance Guide, providing specific technical specifications and current thinking regarding data submissions for review.
This affects manufacturers of biological products, clinical data managers, and regulatory affairs professionals involved in preparing and submitting study data to the FDA.
Adherence to technical conformance guides is critical for avoiding technical rejection or delays during the submission process. This update likely reflects shifts in the agency's data intake capabilities or standardizations requirements, suggesting that sponsors must ensure their data architecture remains compatible with evolving FDA electronic submission environments.
Regulatory and data management teams should perform a gap analysis of current data submission protocols against this updated guide to ensure technical formats align with the FDA's current expectations for biologics data. Systems and software used for clinical and non-clinical data packaging may require verification or updates.
This technical specifications document represents the Food and Drug Administration's (FDA's) current thinking on this topic.
Open in openFDA / FDA.gov